M6D-29208-35859 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-07-13
Dose 1 — Pfizer-BioNTech
Co-administered: Other
2022-08-03
Registered in v-safe
2022-08-03
Dose 2 — Pfizer-BioNTech
2022-08-03
Health check-in — day 0, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-08-05
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · Irritability/crying, Loss of appetite

Under 3 check-in
2022-08-06
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-08-07
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-08-08
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-08-09
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-08-10
Health check-in — day 7, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-08-17
Health check-in — day 14, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-24
Health check-in — day 21, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-09-02
Survey response — day 28, dose 2, under 3
MedDRA: Cough, Rash macular, Rhinorrhoea — Feeling: Good

Free text: Occasional cough, runny nose, blotchy rash for a couple of hours

MedDRA releases: 2024-11 · check-in free text available
2022-09-07
Health check-in — day 35, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-09-16
Health check-in — day 42, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-11-02
Health check-in — 3 months, dose 2, under 3
Feeling: Good

Under 3 check-in
2023-02-01
Survey response — 6 months, dose 2, under 3
MedDRA: Influenza — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

MedDRA releases: 2024-11
2023-02-01
Report sent to call center — 6 months, dose 2, under 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · 1 call case(s)
2023-02-02
Call 1 — Left Voicemail
2023-02-03
Call 2 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-07-13	Pfizer-BioNTech	Other
2	2022-08-03	Pfizer-BioNTech	No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 12 (Under 3) — day 28, dose 2, under 3

2022-09-02

Symptoms: Occasional cough, runny nose, blotchy rash for a couple of hours

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Influenza	·	·	✓
SD	Rash macular	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release